Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Current Oncology Reports
|
February 5, 2019
BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
Sofia Genta, Maria Cristina Pirosa, Anastasios Stathis
Critical Reviews in Oncology/Hematology
|
November 20, 2021
Targeting the DNA damage response: PARP inhibitors and new perspectives in the landscape of cancer treatment
Sofia Genta, Federica Martorana, Anastasios Stathis, et al.
International Journal of Molecular Sciences
|
July 23, 2016
Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?
Gloria Mittica, Sofia Genta, Massimo Aglietta, et al.
International Journal of Molecular Sciences
|
January 21, 2023
Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers
Pavlina Spiliopoulou, Olga Vornicova, Sofia Genta, et al.
Frontiers in Oncology
|
August 29, 2022
Patient-derived cancer models: Valuable platforms for anticancer drug testing
Sofia Genta, Bryan Coburn, David W Cescon, et al.
Trends in Cancer
|
February 6, 2023
Antibody-drug conjugates: in search of partners of choice
Jesús Fuentes-Antrás, Sofia Genta, Abi Vijenthira, et al.
Expert Opinion on Biological Therapy
|
January 9, 2018
Reprogramming T-cells for adoptive immunotherapy of ovarian cancer
Sofia Genta, Eleonora Ghisoni, Gaia Giannone, et al.
Biomedicines
|
July 27, 2024
Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer
Sabrina Nucera, Chiara Conti, Federica Martorana, et al.
Oncotarget
|
November 23, 2017
Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity
Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, et al.
International Journal of Molecular Sciences
|
June 25, 2020
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
Gaia Giannone, Eleonora Ghisoni, Sofia Genta, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Current Oncology Reports
|
February 5, 2019
BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
Sofia Genta, Maria Cristina Pirosa, Anastasios Stathis
Critical Reviews in Oncology/Hematology
|
November 20, 2021
Targeting the DNA damage response: PARP inhibitors and new perspectives in the landscape of cancer treatment
Sofia Genta, Federica Martorana, Anastasios Stathis, et al.
International Journal of Molecular Sciences
|
July 23, 2016
Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?
Gloria Mittica, Sofia Genta, Massimo Aglietta, et al.
International Journal of Molecular Sciences
|
January 21, 2023
Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers
Pavlina Spiliopoulou, Olga Vornicova, Sofia Genta, et al.
Frontiers in Oncology
|
August 29, 2022
Patient-derived cancer models: Valuable platforms for anticancer drug testing
Sofia Genta, Bryan Coburn, David W Cescon, et al.
Trends in Cancer
|
February 6, 2023
Antibody-drug conjugates: in search of partners of choice
Jesús Fuentes-Antrás, Sofia Genta, Abi Vijenthira, et al.
Expert Opinion on Biological Therapy
|
January 9, 2018
Reprogramming T-cells for adoptive immunotherapy of ovarian cancer
Sofia Genta, Eleonora Ghisoni, Gaia Giannone, et al.
Biomedicines
|
July 27, 2024
Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer
Sabrina Nucera, Chiara Conti, Federica Martorana, et al.
Oncotarget
|
November 23, 2017
Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity
Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, et al.
International Journal of Molecular Sciences
|
June 25, 2020
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
Gaia Giannone, Eleonora Ghisoni, Sofia Genta, et al.
Page
of 4